Ipsen Biopharmaceuticals Joins National Pharmaceutical Council
March 28, 2017
March 28, 2017
WASHINGTON, March 28 -- The National Pharmaceutical Council issued the following news release:
The National Pharmaceutical Council (NPC) today announced that Ipsen Biopharmaceuticals, Inc. has joined the health policy research organization as its newest member. David Cox, PhD, Vice President, Medical and Regulatory Affairs (North America), will serve as his company's representative on NPC's Board of Directors.
"We're pleased to have Ipsen and Dr. Cox join NPC a . . .
The National Pharmaceutical Council (NPC) today announced that Ipsen Biopharmaceuticals, Inc. has joined the health policy research organization as its newest member. David Cox, PhD, Vice President, Medical and Regulatory Affairs (North America), will serve as his company's representative on NPC's Board of Directors.
"We're pleased to have Ipsen and Dr. Cox join NPC a . . .